Biodiesel is a non-toxic, biodegradable and renewable fuel produced from vegetable oils, animal fats or recycled cooking oils which can be used in diesel engines. It is considered more environment-friendly than petroleum diesel as it has substantially lower emissions of air pollutants and greenhouse gases. Biodiesel is manufactured through a chemical process called transesterification where the vegetable oil or animal fat reacts with an alcohol in the presence of a catalyst to form fatty acid alkyl esters, commonly referred to as biodiesel, and glycerin.

The Global Biodiesel Catalyst Market is estimated to be valued at US$ 266.69 Bn in 2024 and is expected to exhibit a CAGR of 24.% over the forecast period 2024 To 2031.

Key Takeaways
Key players operating in the Biodiesel Catalyst are Myriad Genetics, Inc., F. Hoffmann-La Roche AG, Invitae Corporation, NeoGenomics Laboratories, Inc., BPS Bioscience, Inc. Antibodies Inc., Networks LLC, Beckman Coulter, Inc., Euro Diagnostica AB, F. Hoffmann-La Roche Ltd., Qiagen NV, Siemens Healthcare GmbH, Bio Rad Laboratories Inc., Exagen Inc., Genway Biotech, Inc., Microdrop LLC (imaware), Svar Life Science AB and Thermo Fisher Scientific Inc.

Key opportunities in the Biodiesel Catalyst Market Demand include rising biodiesel production and growing focus on renewable energy sources. The European Union's Renewable Energy Directive mandates a minimum target of 14% renewable energy in the transport sector by 2030, opening up opportunities for biodiesel suppliers and catalyst manufacturers.
Technological advancements in biodiesel production processes and catalyst formulation have made biodiesel a commercially viable option. For example, the development of immobilized alkali metal catalysts has enabled continuous flow production of biodiesel at lower costs.

Get More Insights On, Biodiesel Catalyst Market